Test Price
2,800 AED✅ Home Collection Available
GGCX Gene Vitamin K‑Dependent Clotting Factors Combined Deficiency Type 1 Genetic Test in UAE
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Price: 2,800 AED | Turnaround Time: 3–4 Weeks | DHA License: 1143
Test Overview & Methodology
This next‑generation sequencing (NGS) test analyses the complete coding region of the GGCX gene to definitively diagnose hereditary combined deficiency of vitamin K‑dependent clotting factors type 1 (VKCFD1). It is the most accurate genetic tool for confirming the condition, guiding personalised haematology management, and enabling family cascade screening. The specimen required is peripheral whole blood, which permits high‑resolution detection of pathogenic single‑nucleotide variants, insertions, deletions, and splice‑site mutations.
| Feature | Our Test (GGCX NGS) | Closest Alternative (Coagulation Factor Assays) |
|---|---|---|
| Precision | 99.9% sensitivity/specificity for GGCX mutations | Indirect; cannot identify carrier status |
| Methodology | NGS with full gene sequencing (LC‑MS/MS validated) | Functional clotting factor activity assays |
| Turnaround Time | 3–4 Weeks | Same day – 1 week |
Physician Insight & Safety Protocols
“This test is not a stand‑alone diagnosis; it must be correlated with a detailed bleeding history and family pedigree. I always advise patients that a positive result answers the genetic question, but a negative result in a clearly affected family may still require further functional studies or whole‑exome sequencing to rule out phenocopies.” – Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration ID: 9294403)
Important Clinical Advisory
Do not discontinue prescribed anticoagulants, vitamin K supplements, or any blood‑thinning therapy without consulting your prescribing physician. Abrupt changes can provoke life‑threatening bleeding or thrombotic events. This genetic result should always be interpreted alongside current medication status.
Patient Exclusion Criteria & ER Red Flags
- Active, uncontrolled bleeding or acute thrombosis – seek emergency care immediately.
- Pregnancy – mandatory genetic counselling and obstetric assessment before sample collection.
- Minors (under 18 years) – legal guardian consent required per Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Recent blood transfusion or factor concentrate infusion – wait at least 2 weeks post‑infusion before blood draw.
Patient FAQ & Clinical Guidance
1. What does the GGCX genetic test reveal about my bleeding disorder?
This test identifies mutations in the GGCX gene that cause combined deficiency of vitamin K‑dependent clotting factors, confirming the hereditary basis of your disorder and guiding targeted treatment. It can also identify asymptomatic carriers within your family for early intervention.
2. How should I prepare for the test, and is a special diet required?
No fasting or dietary restrictions are needed, but you must attend a mandatory pre‑test genetic counselling session to map your family pedigree accurately before the blood draw. Bring records of any prior bleeding episodes or family history of clotting disorders.
3. How long until I receive results, and how will they be explained?
Results are available within 3 to 4 weeks. You will receive a dedicated telephonic post‑clinical guidance session with a haematologist to interpret findings, discuss reproductive risks, and coordinate family cascade testing if indicated.
4. Can this test be performed during pregnancy or on a newborn?
Yes, prenatal and neonatal testing is available but requires close coordination with a maternal‑fetal medicine specialist and informed consent under UAE genetic testing regulations. Sample collection for neonates uses a heel‑prick method rather than venipuncture.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE strictly complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Your genetic data is encrypted, access‑controlled, and never shared without explicit written consent. All clinical testing safety and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. The laboratory holds DHA Facility License Number 1143 and operates under the direct supervision of the Dubai Health Authority.
Clinical & Logistical Metadata
| Test Name | GGCX Gene Vitamin K‑Dependent Clotting Factors Combined Deficiency Type 1 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA or ACD tube) |
| Methodology Used | Next‑Generation Sequencing (NGS) – Full Gene Sequencing with Sanger Confirmation |
| ICD-10-CM Code | D68.8 |
| LOINC Code | 81247-9 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians